Spain leads EUCanScreen’s communications for March 2025
Stay tuned for more news on Spain’s Cancer Screening updates!
Spain has been selected as the Screening Campaign Country of the month for March 2025.
The Catalan Institute of Oncology (ICO) was assigned as the Competent Authority representing Spain. There are five Spanish Affiliated Entities participating in EUCanScreen:
- – Instituto Aragonés de Ciencias de la Salud (IACS) IACS | IACS
- – Instituto de Investigación Sanitaria de Valdecilla (IDIVAL) Inicio – IDIVAL
- – Instituto de Investigaciónj en Sistemas de Salud (Biosistemak) Instituto de Investigación en Sistemas de Salud Biosistemak
- – Fundación per al Foment de la Investigació Sanitaria i Biomedica de la Comunitat Valenciana (Fisabio) FISABIO | Fisabio
- – Institut de Investigació Hospital del Mar (IMIM) Hospital del Mar Research Institute
Between the Competent Authority and its Affiliated Entities, Spain has a significant contribution in all Work Packages of EUCanScreen.
ICO Leads Work Package 7 – Implementation Research to improve the existing cancer screening programmes and Co-Leads T7.1 Implementing Quality assurance (QA) scheme alongside UCY, Cyprus. ICO also Leads on T7.5 Implementing informed decision-making in population-based cancer screening programmes.
IACS Co-leads T5.5 Piloting developed standardised data model for Euorpean Health Data Space (EHDS) alongside CSF, Finland.
Within the following weeks, each Spanish institution participating in EUCanScreen will post an update on their specific involvement and contributions to the project.
Spain has a decentralised cancer screening structure. The Ministry of Health is responsible for national planning and regulation, while regional health authorities manage operational aspects. Therefore, during March, Spanish institutions will share news relating to their regional screening programmes, updates and advancements.
Stay tuned this March for more information on Spain’s contributions to making cancer screening more accessible and effective across Europe.
Subscribe to our newsletter to get news and updates.
Subscribe to our newsletter to get news and updates.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959
